Early functional effects of Clostridium difficile toxin A on human colonocytes

Gastroenterology
J E BrankaC Laboisse

Abstract

Previous in vitro studies have shown that Clostridium difficile toxin A is able to directly affect the intestinal epithelial barrier function. The aim of this study was to examine the early effects of toxin A on mucin exocytosis and determine whether this toxin can induce the production of the chemokine interleukin 8 (IL-8) from human colonic epithelial cells. Two model systems were used: the HT29-CI.16E colonic goblet cell line and primary cultures of human normal colonocytes. Toxin A exerted a rapid and dose-related inhibition of stimulated mucin exocytosis without altering baseline (constitutive) mucin exocytosis from HT29-CI.16E cells. Toxin A was also able to induce the secretion of IL-8 from both HT29-CI.16E cells and primary cultures of human normal colonocytes, as early as 2-3 hours of incubation. The results show that while toxin A is able to down-regulate stimulated mucin exocytosis, it is able to up-regulate the secretion of an important chemoattractant chemokine, IL-8. These modifications illustrate the ability of colonocytes to recruit inflammatory and immune cells that will eventually bring about major mucosal damage.

Citations

Dec 5, 2013·Mucosal Immunology·D Ortiz-MasiáM D Barrachina
Jul 1, 2010·Toxins·Xingmin SunHanping Feng
Jul 6, 2014·Journal of Immunology Research·Stefano BibbòGiovanni Cammarota
Oct 23, 2012·Trends in Molecular Medicine·Rajat Madan, William A Petri
Jan 24, 2015·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Carlos GamazoJ M Irache
Jul 26, 2005·The Journal of Pathology·Frédérique Blanchot-JossicJean-François Mosnier
Mar 24, 2016·Fish & Shellfish Immunology·Bassem Allam, Emmanuelle Pales Espinosa
Jul 23, 2015·Inflammatory Bowel Diseases·Tanya M MonaghanYashwant R Mahida
Apr 4, 2015·Tissue Barriers·Steve CornickKris Chadee
Jan 13, 2015·Infectious Disease Clinics of North America·Tanya M Monaghan
Mar 27, 1999·European Journal of Clinical Investigation·A BourreilleH M Blottière
Feb 1, 2013·Therapeutic Advances in Infectious Disease·Katie Solomon
Oct 20, 2017·FEMS Microbiology Reviews·Ramyavardhanee Chandrasekaran, D Borden Lacy
Aug 17, 2004·American Journal of Physiology. Gastrointestinal and Liver Physiology·E GaudierC Hoebler
Oct 26, 2001·Nature·M BarbierM P Wymann
Jul 4, 2007·Journal of the American Veterinary Medical Association·Adam J Moeser, Anthony T Blikslager
Jan 2, 2015·American Journal of Physiology. Gastrointestinal and Liver Physiology·Melinda A EngevikRoger T Worrell
Sep 21, 2000·Journal of Pediatric Gastroenterology and Nutrition·L V McFarlandS Guandalini
Sep 25, 2014·The Journal of Trauma and Acute Care Surgery·Alicia OlsonDavid M Liberati
Jun 24, 2004·Clinical Science·Yashwant R Mahida, Vivien E Rolfe
Jun 13, 2003·American Journal of Physiology. Gastrointestinal and Liver Physiology·M NeunlistJ P Galmiche
Feb 15, 2019·Frontiers in Microbiology·Simona IacobLuminita Monica Luminos
Apr 1, 2020·American Journal of Physiology. Gastrointestinal and Liver Physiology·Melinda A EngevikJames Versalovic
Feb 24, 2001·American Journal of Physiology. Gastrointestinal and Liver Physiology·C Pothoulakis, J T Lamont
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sungwon ChaeMartin F Kagnoff
Sep 21, 2017·Frontiers in Cellular and Infection Microbiology·Jean-Félix SicardJosée Harel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.